Literature DB >> 17570480

FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

Tao Zuo1, Lizhong Wang, Carl Morrison, Xing Chang, Huiming Zhang, Weiquan Li, Yan Liu, Yin Wang, Xingluo Liu, Michael W Y Chan, Jin-Qing Liu, Richard Love, Chang-Gong Liu, Virginia Godfrey, Rulong Shen, Tim H-M Huang, Tianyu Yang, Bae Keun Park, Cun-Yu Wang, Pan Zheng, Yang Liu.   

Abstract

The X-linked Foxp3 is a member of the forkhead/winged helix transcription factor family. Germline mutations cause lethal autoimmune diseases in males. Serendipitously, we observed that female mice heterozygous for the "scurfin" mutation of the Foxp3 gene (Foxp3(sf/+)) developed cancer at a high rate. The majority of the cancers were mammary carcinomas in which the wild-type Foxp3 allele was inactivated and HER-2/ErbB2 was overexpressed. Foxp3 bound and repressed the HER-2/ErbB2 promoter. Deletion, functionally significant somatic mutations, and downregulation of the FOXP3 gene were commonly found in human breast cancer samples and correlated significantly with HER-2/ErbB2 overexpression, regardless of the status of HER-2 amplification. Our data demonstrate that FOXP3 is an X-linked breast cancer suppressor gene and an important regulator of the HER-2/ErbB2 oncogene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570480      PMCID: PMC1974845          DOI: 10.1016/j.cell.2007.04.034

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  35 in total

Review 1.  Breast and ovarian cancer.

Authors:  Richard Wooster; Barbara L Weber
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

2.  Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation.

Authors:  Hogune Im; Jeffrey A Grass; Kirby D Johnson; Meghan E Boyer; Jing Wu; Emery H Bresnick
Journal:  Methods Mol Biol       Date:  2004

Review 3.  X-chromosome genetics and human cancer.

Authors:  Alain Spatz; Christophe Borg; Jean Feunteun
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

4.  High frequency of mutations of the PIK3CA gene in human cancers.

Authors:  Yardena Samuels; Zhenghe Wang; Alberto Bardelli; Natalie Silliman; Janine Ptak; Steve Szabo; Hai Yan; Adi Gazdar; Steven M Powell; Gregory J Riggins; James K V Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Science       Date:  2004-03-11       Impact factor: 47.728

5.  Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype.

Authors:  Laura Roncuzzi; Irene Brognara; Stefania Cocchi; Wainer Zoli; Anna Gasperi-Campani
Journal:  Cancer Genet Cytogenet       Date:  2002-06

6.  HER-2 testing in breast cancer using parallel tissue-based methods.

Authors:  Hadi Yaziji; Lynn C Goldstein; Todd S Barry; Robert Werling; Harry Hwang; Georgiana K Ellis; Julie R Gralow; Robert B Livingston; Allen M Gown
Journal:  JAMA       Date:  2004-04-28       Impact factor: 56.272

7.  Detection and quantitation of HER-2 gene amplification and protein expression in breast carcinoma.

Authors:  Anna M Bofin; Borgny Ytterhus; Cara Martin; John J O'Leary; Bjørn M Hagmar
Journal:  Am J Clin Pathol       Date:  2004-07       Impact factor: 2.493

8.  Cancer. Addiction to oncogenes--the Achilles heal of cancer.

Authors:  I Bernard Weinstein
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

9.  The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.

Authors:  A L Schechter; D F Stern; L Vaidyanathan; S J Decker; J A Drebin; M I Greene; R A Weinberg
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

View more
  164 in total

1.  Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers.

Authors:  Cecilia Hermans; David Anz; Jutta Engel; Thomas Kirchner; Stefan Endres; Doris Mayr
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

2.  Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.

Authors:  Weiquan Li; Lizhong Wang; Hiroto Katoh; Runhua Liu; Pan Zheng; Yang Liu
Journal:  Cancer Res       Date:  2011-01-28       Impact factor: 12.701

3.  X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity.

Authors:  Yang Liu; Lizhong Wang; Pan Zheng
Journal:  Trends Genet       Date:  2010-04-29       Impact factor: 11.639

Review 4.  E3 ubiquitin ligases in ErbB receptor quantity control.

Authors:  Kermit L Carraway
Journal:  Semin Cell Dev Biol       Date:  2010-09-22       Impact factor: 7.727

5.  Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells.

Authors:  Sheng Tan; Keshuo Ding; Qing-Yun Chong; Junsong Zhao; Yuan Liu; Yunying Shao; Yuanyuan Zhang; Qing Yu; Zirui Xiong; Weijie Zhang; Min Zhang; Gaopeng Li; Xiaoni Li; Xiangjun Kong; Akhlaq Ahmad; Zhengsheng Wu; Qiang Wu; Xiaodong Zhao; Peter E Lobie; Tao Zhu
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

6.  Foxp3 promoter polymorphism (rs3761548) in breast cancer progression: a study from India.

Authors:  Parveen Jahan; V R Vinish Ramachander; G Maruthi; S Nalini; K Prasanna Latha; T S R Murthy
Journal:  Tumour Biol       Date:  2013-12-13

Review 7.  FOXP3 as an X-linked tumor suppressor.

Authors:  Lizhong Wang; Runhua Liu; Mark Ribick; Pan Zheng; Yang Liu
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

8.  Regulation of MHC class I expression by Foxp3 and its effect on regulatory T cell function.

Authors:  Jie Mu; Xuguang Tai; Shankar S Iyer; Jocelyn D Weissman; Alfred Singer; Dinah S Singer
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

Review 9.  Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice.

Authors:  Brian J Skaggs; Ram Pyare Singh; Bevra H Hahn
Journal:  Hum Immunol       Date:  2008-09-24       Impact factor: 2.850

10.  Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways.

Authors:  Emil Heinze; Grace Chan; Rachel Mory; Raz Khavari; Asif Alavi; Sue Y Chung; Robert N Nishimura; Richard H Weisbart
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.